Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : YP05002
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of YP05002 in Healthy Participants
Details : YP05002 is a drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Overweight.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 28, 2025
Lead Product(s) : YP05002
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable